Synergy CHC Files Chapter 11 After Costco Drops Focus Factor

TheStreet·15 Sep 2026·

·Read original

3▲1 ▼2Impact / 5

Corporate Action Earnings Personal Care Products

SNYR ▼

RKT.LSE ▲

COST ▼

Summary · why it matters

Synergy CHC Corp., the maker of Focus Factor, filed for Chapter 11 bankruptcy on September 4, 2026, in the U.S. Bankruptcy Court for the District of Columbia after Costco told the company in July it would discontinue Focus Factor products following a 16-year relationship. Costco accounted for approximately 58% of Synergy's net revenue in the fiscal year ended December 31, 2025, and its decision triggered an $18.9 million debt acceleration from the company's lender. Reckitt Benckiser, whose Neuriva brain supplement is already sold at Costco for $43.99 per 50-capsule bottle, is positioned as the clearest beneficiary, with H1 2026 Core Reckitt like-for-like net revenue growth of 2.7% accelerating to 4.2% in the second quarter, a 60.9% gross profit margin, a 24.8% adjusted operating profit margin, £419 million in first-half free cash flow, and roughly £3 billion returned to shareholders through dividends and buybacks. Reckitt also announced a 5% increase in its interim dividend and an additional £500 million share buyback, with full-year 2026 guidance calling for 4% to 5% like-for-like net revenue growth in Core Reckitt. RBGLY trades at $14.00, down 10.62% year-to-date, with a trailing P/E of 11.36 and a forward P/E of 14.24.

Synergy CHC Corp. Common Stock ▼

Reckitt Benckiser Group PLC ▲

Costco Wholesale Corp ▼